MedPath

Inflammation Markers in Hyperemesis Gravidarum

Completed
Conditions
Hyperemesis Gravidarum
Registration Number
NCT06245811
Lead Sponsor
Izzet Celegen
Brief Summary

In this study, the relationship between the severity of hyperemesis gravidarum (HEG) disease and subclinical inflammatory factors such as Platelet Crit (PCT), Hemoglobin/red cell distribution width ratio (HRR), Neutrophil/lymphocyte ratio (NLR), was investigated.

Detailed Description

A total of 215 pregnant women, 102 with hyperemesis gravidarum and 113 healthy pregnant women, were included in the study. HEG patients were divided into three groups according to the modified PUQE classification: mild (n=38), moderate (n=32) and severe (n=32).

In our study, we proposed using a new prognostic marker for HEG patients. We think that our study will be a source for future studies on HEG.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
215
Inclusion Criteria
  • Healthy pregnant women over 18 years of age
  • 5-16 weeks of gestation.
Exclusion Criteria

Smoking, urinary tract infections, previously diagnosed psychological disorders, gastrointestinal disorders, multiple pregnancies, eating disorders, thyroid disorders, inflammatory disease, pregnancy with assisted fertilization technique.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The Pregnancy Unique Quantification of Emesis/Stomach scoring system2 months

1: Weight loss of 5% or more since the beginning of pregnancy 2: Vomiting at least three times a day 3: A ketonuria value of +1 or higher on a urinalysis test

Secondary Outcome Measures
NameTimeMethod
Body mass index2 months

(BMI) (kg/m2) was obtained by dividing body weight (kg) by height (m2) squared

Trial Locations

Locations (1)

Yuzuncu Yil University, Faculty of Medicine

🇹🇷

Van, Turkey

© Copyright 2025. All Rights Reserved by MedPath